dr. karmali on the importance of evaluating older patients with mcl in the rituximab era
Published 4 years ago • 69 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
0:50
dr. karmali on treating older patients with mcl in the rituximab era
-
1:21
dr. karmali on optimizing maintenance therapy in older patients with mcl
-
1:31
dr. karmali on challenges in mcl
-
2:20
dr. karmali on ibrutinib maintenance following induction in untreated mcl
-
1:11
dr. karmali on next steps of research regarding ibrutinib maintenance in mcl
-
3:53
treatment approaches for older patients with mcl
-
1:23
dr. rule on the future treatment paradigm in mcl
-
1:38
dr. kaplan discusses rituximab maintenance in mcl
-
3:43
geoff's story: living well with mantle cell lymphoma (mcl)
-
10:31
rituximab infusion | what i packed what went down!
-
2:06
padmini pillai on immunogenic death for cancer cells
-
1:50
dr. hilal on the benefit of maintenance rituximab in patients with mcl
-
1:50
acalabrutinib and rituximab as first-line therapy for older patients with mcl
-
0:57
dr. rule on treatment of young, fit patients with mcl
-
1:33
dr. jacobs on the efficacy of ibrutinib and acalabrutinib in patients with mcl
-
0:58
dr. kolibaba on mechanism of action with entospletinib in mcl
-
2:00
dr. rule on standard of care in mcl
-
1:18
dr. ansell on promising combinations being studied in mcl
-
2:17
management of older adults with mantle-cell lymphoma
-
1:59
rituximab maintenance key to outcome improvement in mantle cell lymphoma
-
27:36
clinical considerations for the treatment of elderly mcl patients
-
1:01
dr. kolibaba on entospletinib activity in mantle cell lymphoma